Competition forcing marriage of iPads, ops data for execs

"We can't ignore any data telling us about the effectiveness of our business strategies," Pfizer ($PFE) VP for U.S. commercial ops David Kreutter told MIT Sloan Management Review. The stakes are too high for execs to eschew tablet PCs; "analytics has become much more operational than in the past," he said, echoing VP/GM Andy Amalfitano of Solarsoft Business Systems: "[The iPad] can be even more powerful in the hands of management, looking at every strategic advantage that could boost the bottom line. That's where manufacturing intelligence comes into play." Interview

Suggested Articles

Transporting pharmaceutical products at <-60C for more than 96 hours has seemed an insurmountable challenge. TOWER’s solution has solved the problem.

Roche will spend $500 million for a new global manufacturing logistics hub in Canada that will eventually employ 500 workers in Ontario.

Fledgling Indiana CDMO Incog BioPharma Services is shelling out $60 million to get its first manufacturing facility off the ground.